AG
Artal Group Portfolio holdings
AUM
$930M
This Quarter Return
+13.39%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$1.92B
AUM Growth
+$1.92B
(+6.5%)
Cap. Flow
+$74M
Cap. Flow
% of AUM
3.86%
Top 10 Holdings %
Top 10 Hldgs %
43%
Holding
144
New
9
Increased
16
Reduced
9
Closed
11
Top Buys
| 1 |
Apellis Pharmaceuticals
APLS
|
$68.3M |
| 2 |
Lexicon Pharmaceuticals
LXRX
|
$44.6M |
| 3 |
SWTX
SpringWorks Therapeutics
SWTX
|
$32.9M |
| 4 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$28.1M |
| 5 |
KLRS
Kalaris Therapeutics, Inc. Common Stock
KLRS
|
$25.7M |
Top Sells
| 1 |
argenx
ARGX
|
$88.3M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
$87.5M |
| 3 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$23.9M |
| 4 |
SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
|
$16.3M |
| 5 |
Cytokinetics
CYTK
|
$13.3M |
Sector Composition
| 1 | Healthcare | 95.18% |
| 2 | Consumer Discretionary | 3.54% |
| 3 | Financials | 0.61% |
| 4 | Consumer Staples | 0.21% |
| 5 | Industrials | 0.19% |
